申请人:Duquesne University of the Holy Spirit
公开号:US10167287B2
公开(公告)日:2019-01-01
This invention provides substituted pyrimidine compounds having the formula:
wherein X is absent, CH2, S, or O, and R is an alkyl group having from one to ten carbon atoms, and optionally salts, hydrates, or solvates thereof, that are useful in treating a patient having a disease or cancer. The compounds of this invention are useful as multi-enzyme antifolates selectively targeting the folate receptor (FR). Further, a method of making 5- and 6-substituted cyclopenta[d]pyrimidine for nonclassical and classical antifolates as TS and DHFR inhibitors is provided.
本发明提供了具有以下式子的取代嘧啶化合物:
其中,X 为无、CH2、S 或 O,R 为具有一至十个碳原子的烷基,以及可选的盐类、水合物或溶液,这些化合物可用于治疗疾病或癌症患者。本发明的化合物作为选择性靶向叶酸受体(FR)的多酶抗叶酸盐是有用的。此外,本发明还提供了一种制造 5-和 6-取代环戊并[d]嘧啶的方法,用于作为 TS 和 DHFR 抑制剂的非经典和经典抗叶酸盐。